Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
J Neurol Neurosurg Psychiatry ; 79(8): 895-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18096680

ABSTRACT

BACKGROUND AND AIMS: Published data suggest that patients with cerebral ischaemia and atrial fibrillation (CIAF) have higher inhospital mortality than patients with cerebral ischaemia of arterial origin (CIAO). Data on long term risks are scarce. We compared the long term risks of death and vascular events (VE) between these groups. METHODS: We extended the follow-up of 2473 patients from the Dutch TIA Trial (recruitment March 1986 to March 1989, all treated with aspirin; CIAO) and 186 Dutch participants of the European Atrial Fibrillation Trial (recruitment June 1988 to May 1992, 26% on anticoagulants during the trial; CIAF). Hazard ratios (HRs) for death and VE of CIAF versus CIAO were analysed by means of Cox regression analysis and adjusted for age, sex and several cardiovascular risk factors. RESULTS: After a mean follow-up of 10.1 years, 1484 patients with CIAO had died and 1336 had suffered at least one VE (377 cardiac, 455 stroke). Mean follow-up of the CIAF patients was 6.8 years; 150 patients had died and 136 had suffered at least one VE (41 cardiac, 63 stroke). Adjusted HRs (CIAF vs CIAO) were 1.46 (95% CI 1.22 to 1.74) for death, 1.49 (1.24 to 1.79) for first VE, 1.94 (1.47 to 2.55) for first stroke and 1.41 (1.01 to 1.96) for first cardiac event. These HRs were essentially the same as those for the duration of the trials. CONCLUSION: Our study shows that the long term risk of death or vascular events is 1.5 times higher in patients with CIAF than in those with CIAO, after adjustment for differences between the groups.


Subject(s)
Atrial Fibrillation/mortality , Cerebral Hemorrhage/mortality , Cerebral Infarction/mortality , Death, Sudden, Cardiac/epidemiology , Heart Failure/mortality , Ischemic Attack, Transient/mortality , Myocardial Infarction/mortality , Aged , Anticoagulants/therapeutic use , Aspirin/therapeutic use , Atrial Fibrillation/complications , Atrial Fibrillation/drug therapy , Cause of Death , Cerebral Hemorrhage/etiology , Cerebral Hemorrhage/prevention & control , Cerebral Infarction/etiology , Cerebral Infarction/prevention & control , Cohort Studies , Death, Sudden, Cardiac/etiology , Death, Sudden, Cardiac/prevention & control , Disease-Free Survival , Double-Blind Method , Drug Therapy, Combination , Female , Follow-Up Studies , Heart Failure/etiology , Heart Failure/prevention & control , Hospital Mortality , Humans , Ischemic Attack, Transient/drug therapy , Ischemic Attack, Transient/etiology , Male , Middle Aged , Multivariate Analysis , Myocardial Infarction/etiology , Myocardial Infarction/prevention & control , Netherlands , Proportional Hazards Models , Risk Factors , Warfarin/therapeutic use
2.
J Neurol ; 254(8): 1018-25, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17385080

ABSTRACT

BACKGROUND: Stroke has a major impact on survivors. Our study was designed to describe the mental status and health-related quality of life (HRQoL) in long-term survivors of TIA or minor ischaemic stroke (MIS) and evaluate associations of mental and physical factors with HR-QoL. METHODS: A random sample of the 10-year survivors of the Dutch TIA Trial (DTT) and the dutch participants of the European Atrial Fibrillation Trial (EAFT) were interviewed by postal questionnaire (n = 468) and at home (n = 198). Demographic data, mental health status (depression (CES-D), cognition (CAMCOG)), and health perception (SF-36 and Euroqol) were measured. RESULTS: 198 long-term survivors were included; mean age was 72.5 (SD 8.7 years), 22% was depressed (CES-D > or = 16) and 15% had cognitive dysfunction (CAMCOG < 80). The overall HR-QoL did not differ much from the norm population. Physical disability, occurrence of a major stroke and comorbidity of locomotion or the heart were independently associated with a low health perception. CONCLUSIONS: Despite varying amounts of disability, the majority of long-term survivors of a TIA or MIS rated their quality of life as rather good. Physical factors, rather than mental status were independently related to a decrease in perceived health.


Subject(s)
Brain Ischemia/physiopathology , Brain Ischemia/psychology , Health Status , Quality of Life , Aged , Aged, 80 and over , Brain Ischemia/epidemiology , Brain Ischemia/mortality , Disabled Persons/statistics & numerical data , Female , Humans , Longitudinal Studies , Male , Regression Analysis , Retrospective Studies , Surveys and Questionnaires , Survivors
3.
J Neurol Neurosurg Psychiatry ; 77(11): 1238-43, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16735396

ABSTRACT

BACKGROUND: Stroke may have a major effect on survivors and on the healthcare system. AIMS: To study the functional status and use of healthcare facilities in long-term survivors of a transient ischaemic attack (TIA) or minor ischaemic stroke (MIS) and evaluate associations with baseline and follow-up characteristics. METHODS: Follow-up of patients who had participated in the Dutch TIA Trial or the European Atrial Fibrillation Trial was extended to a mean period of 15.6 years. Patients were interviewed through a postal questionnaire (n = 468) and a sample of this group was also interviewed at home (n = 198). Demographic data, information on comorbidity, functional status (Barthel Index, Frenchay Activities Index and modified Rankin Scale) and use of healthcare facilities were recorded. RESULTS: About one third of the survivors interviewed at home experienced any residual disability and 26% were moderately to severely handicapped. Factors associated with poor functional status were advanced age and the presence of any infarct on a baseline computed tomography scan, the recurrence of a new major stroke or the presence of comorbidity of locomotion. One third of survivors used any kind of professional care, which was predominantly related to the functional status at follow-up. CONCLUSIONS: Recurrent stroke and the presence of comorbidity of locomotion are important determinants of long-term disability of survivors of a TIA or an MIS, which, in turn, is strongly associated with the long-term use of professional care. The need for measuring comorbidity with regard to functional status is recommended in research on stroke outcome.


Subject(s)
Disabled Persons , Health Facilities/statistics & numerical data , Ischemic Attack, Transient/rehabilitation , Stroke Rehabilitation , Survivors , Comorbidity , Female , Follow-Up Studies , Health Status , Humans , Ischemic Attack, Transient/complications , Male , Middle Aged , Motor Skills Disorders/etiology , Recurrence , Stroke/complications
4.
Ned Tijdschr Geneeskd ; 149(29): 1620-4, 2005 Jul 16.
Article in Dutch | MEDLINE | ID: mdl-16078770

ABSTRACT

OBJECTIVE: Description of the characteristics of (suspected) child abuse after the establishment of a Child Abuse Team and the introduction of guidelines on how to deal with child abuse and a standardised registration form for suspicions of child abuse. DESIGN: Retrospective. METHOD: An inventory and analysis of the available data on the reporting of, approach to and care provided in case of(suspected) child abuse from I January 2oo0 to 30 April 2004 in the VU Medical Centre in Amsterdam, the Netherlands. RESULTS: The Child Abuse Team received 220 reports of suspected child abuse and the number of suspected and confirmed cases of child abuse increased each year. In 58 suspected cases, the suspicions were confirmed on the basis of additional information from the general practitioners or other attending physicians, or conversations with the parents and the child. There were 29 girls and 29 boys; 22 of them were from families with multiple problems. Of these 58 confirmed cases, 31 were reported to the national Advisory Centre for Registration of Child Abuse. In 120 of the 220 suspected cases of child abuse, this suspicion was refuted, while in 42 cases the suspicion could neither be refuted nor confirmed. CONCLUSION: An increased number of suspected cases of child abuse were reported and confirmed each year following the introduction of a standardised registration form and subsequent analysis by a multidisciplinary team. Broader application of this approach may contribute to improved insight into the prevalence and causes of child abuse.


Subject(s)
Child Abuse , Mandatory Reporting , Patient Care Team , Adolescent , Child , Child Abuse/prevention & control , Child Abuse/statistics & numerical data , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Netherlands , Retrospective Studies
5.
Lancet ; 365(9477): 2098-104, 2005.
Article in English | MEDLINE | ID: mdl-15964446

ABSTRACT

BACKGROUND: Determinants of survival and of risk of vascular events after transient ischaemic attack (TIA) or minor ischaemic stroke are not well defined in the long term. We aimed to restudy these risks in a prospective cohort of patients after TIA or minor ischaemic stroke (Rankin grade< or =3), after 10 years or more. METHODS: We assessed the survival status and occurrence of vascular events in 2473 participants of the Dutch TIA Trial (recruitment in 1986-89; arterial cause of cerebral ischaemia). We included 24 hospitals in the Netherlands that recruited at least 50 patients. Primary outcomes were all-cause mortality and the composite event of death from all vascular causes, non-fatal stroke, and non-fatal myocardial infarction. We assessed cumulative risks by Kaplan-Meier analysis and prognostic factors with Cox univariate and multivariate analysis. FINDINGS: Follow-up was complete in 2447 (99%) patients. After a mean follow-up of 10.1 years, 1489 (60%) patients had died and 1336 (54%) had had at least one vascular event. 10-year risk of death was 42.7% (95% CI 40.8-44.7). Age and sex-adjusted hazard ratios were 3.33 (2.97-3.73) for age over 65 years, 2.10 (1.79-2.48) for diabetes, 1.77 (1.45-2.15) for claudication, 1.94 (1.42-2.65) for previous peripheral vascular surgery, and 1.50 (1.31-1.71) for pathological Q waves on baseline electrocardiogram. 10-year risk of a vascular event was 44.1% (42.0-46.1). After falling in the first 3 years, yearly risk of a vascular event increased over time. Predictive factors for risk of vascular events were similar to those for risk of death. INTERPRETATION: Long-term secondary prevention in patients with cerebral ischaemia still has room for further improvement.


Subject(s)
Cardiovascular Diseases/complications , Ischemic Attack, Transient/mortality , Stroke/mortality , Aged , Cohort Studies , Disease-Free Survival , Female , Humans , Ischemic Attack, Transient/complications , Male , Prognosis , Risk , Risk Factors , Stroke/complications
6.
J Reprod Immunol ; 59(1): 29-37, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12892901

ABSTRACT

C-reactive protein (CRP) is a marker of tissue damage and inflammation. Maternal levels of CRP are elevated in overt preeclampsia, but there is still debate about its use as a predictive marker for preeclampsia during the first and second trimesters of pregnancy. In this study, we measured CRP levels during the first trimester of pregnancy in women who later developed preeclampsia or gave birth to a growth-restricted baby. In total, 107 women from a low-risk population participated in the study, six women developed preeclampsia and nine gave birth to a growth-restricted baby. Although there is a large overlap in measured CRP levels between the three groups, mean CRP levels were significantly elevated in women who later developed preeclampsia (P=0.031) or delivered a growth-restricted baby (P=0.041) when compared with women from the control group, matched for maternal and gestational age, parity, and gravidity. This study shows that in a low-risk population, CRP levels are already elevated between weeks 10 and 14 in pregnant women who develop preeclampsia or deliver a growth-restricted baby.


Subject(s)
C-Reactive Protein/metabolism , Fetal Growth Retardation/complications , Pre-Eclampsia/blood , Pregnancy Complications, Cardiovascular/blood , Pregnancy Trimester, First/blood , Birth Weight , Blood Pressure , Case-Control Studies , Female , Fetal Growth Retardation/blood , Fetal Growth Retardation/physiopathology , Humans , Infant, Newborn , Organ Size , Placenta/blood supply , Placenta/pathology , Placenta/physiopathology , Pre-Eclampsia/complications , Pre-Eclampsia/physiopathology , Pregnancy , Pregnancy Complications, Cardiovascular/physiopathology
7.
Obstet Gynecol ; 98(4): 600-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11576575

ABSTRACT

OBJECTIVE: Previous studies have shown decreased levels of placenta growth factor in serum of pregnant women with preeclampsia. The aim of this study was to investigate whether levels of placenta growth factor are decreased before the clinical onset of preeclampsia, and whether placenta growth factor levels are decreased in pregnancies complicated by intrauterine growth restriction. METHODS: From an ongoing longitudinal study, 101 plasma samples were collected from 72 pregnant women at weeks 11-21 of gestation. Placenta growth factor levels were determined retrospectively in plasma using an enzyme-linked immunosorbent assay. Correlations between plasma concentrations of placenta growth factor and pregnancy outcome were evaluated. RESULTS: Plasma samples of 72 patients were analyzed. Forty-four patients had no pregnancy complications, 18 developed preeclampsia, and 10 women had pregnancies complicated by intrauterine growth restriction. Between week 17 and week 21 of pregnancy, a significantly lower level of placenta growth factor was found in plasma of patients who later developed preeclampsia (n = 10), compared with control pregnancies (n = 25, P = .004). In women with a growth-restricted baby at birth (n = 5), levels of placenta growth factor were also low. CONCLUSIONS: Our results show that plasma placenta growth factor levels are decreased before preeclampsia is clinically evident. The data suggest that placenta growth factor may be useful to determine the relative risk of developing preeclampsia and intrauterine growth restriction.


Subject(s)
Pre-Eclampsia/blood , Pregnancy Proteins/blood , Pregnancy Trimester, First/blood , Pregnancy Trimester, Second/blood , Adult , Case-Control Studies , Female , Fetal Growth Retardation/blood , Humans , Longitudinal Studies , Multivariate Analysis , Placenta Growth Factor , Pre-Eclampsia/diagnosis , Pregnancy
8.
Placenta ; 22(6): 511-8, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11440538

ABSTRACT

Placental development involves control by the basic helix-loop-helix transcription factor Mash2. Transcript analysis of the Human Achaete Scute Homolog 2 (HASH2) mRNA revealed the presence of two overlapping transcripts in first trimester placentae. The two transcripts (2.6 and 1.5 kb) are generated by two promotors which are separated by 1.1 kb, generating transcripts 1 and 2, respectively. Surprisingly, in transcript 1 which shows a broad expression, a second potential coding region, tentatively called Human Achaete Scute Associated Protein (HASAP) was present. Transcript 2 contains the HASH2 encoding region only. Analysis of protein expression from both transcripts by transfection studies with eGFP fusion proteins, revealed that both coding regions are translated from their endogenous translation initiation site and showed that both proteins are transported to the nucleus. HASH2 is distributed throughout the nucleus but the HASAP protein is transported into nuclear compartments, the nucleoli. In addition, the HASAP protein lacks the bHLH domain and bears no homology to known proteins. Moreover, allele-specific RT-PCR showed the human gene not to be subject to imprinting, possibly reflecting the biallelic expression of one of both transcripts. Our data indicate a species-specific difference between mouse and human expression of the Achaete Scute Homolog 2 and suggests a dual function of the human homologue.


Subject(s)
Cell Nucleus/chemistry , DNA-Binding Proteins/genetics , Promoter Regions, Genetic , RNA, Messenger/genetics , Transcription Factors , Alleles , Animals , Basic Helix-Loop-Helix Transcription Factors , Cell Line , DNA-Binding Proteins/analysis , DNA-Binding Proteins/metabolism , Female , Gene Expression , Green Fluorescent Proteins , Humans , Luminescent Proteins/genetics , Mice , Placenta/chemistry , Pregnancy , Pregnancy Trimester, First , RNA, Messenger/analysis , Recombinant Fusion Proteins , Reverse Transcriptase Polymerase Chain Reaction , Species Specificity , Transfection
9.
Genomics ; 73(3): 331-7, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11350125

ABSTRACT

In the mouse, expression of an antisense Igf2r RNA (Air) is correlated with Igf2r repression on the paternal allele. One of the possible models for Igf2r repression could be through promoter competition or through the action of the Air RNA, in, e.g., transcriptional interference or repressor binding. These models predict the conservation of AIR RNA in human samples with monoallelic IGF2R expression and the production of AIR RNA in first-trimester human tissues. However, by strand-specific RT-PCR and by ribonuclease protection assay we have not detected any AIR RNA in first-trimester placental tissue samples, not even in samples that downregulate IGF2R expression in an allele-specific manner. This indicates that in contrast to the mouse, allelic IGF2R repression in the developing human placenta does not correlate with AIR expression.


Subject(s)
Gene Expression Regulation/genetics , Placenta/metabolism , RNA, Antisense/genetics , Receptor, IGF Type 2/genetics , Alleles , Female , Gene Expression , Genomic Imprinting , Humans , Nuclease Protection Assays , Pregnancy , Pregnancy Trimester, First , RNA, Antisense/analysis , RNA, Antisense/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Substrate Specificity , Transcription, Genetic
10.
Dev Biol ; 234(1): 151-60, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11356026

ABSTRACT

cAMP oscillations, generated by adenylyl cyclase A (ACA), coordinate cell aggregation in Dictyostelium and have also been implicated in organizer function during multicellular development. We used a gene fusion of the ACA promoter with a labile lacZ derivative to study the expression pattern of ACA. During aggregation, most cells expressed ACA, but thereafter expression was lost in all cells except those of the anterior tip. Before aggregation, ACA transcription was strongly upregulated by nanomolar cAMP pulses. Postaggregative transcription was sustained by nanomolar cAMP pulses, but downregulated by a continuous micromolar cAMP stimulus and by the stalk-cell-inducing factor DIF. Earlier work showed that the transcription factor StatA displays tip-specific nuclear translocation and directs tip-specific expression of the nuclear protein CudA, which is essential for culmination. Both StatA and CudA were present in nuclei throughout the entire slug in an aca null mutant that expresses ACA from the constitutive actin15 promoter. This suggests that the tip-specific expression of ACA directs tip-specific nuclear translocation of StatA and tip-specific expression of CudA.


Subject(s)
Adenylyl Cyclases/biosynthesis , Cyclic AMP/metabolism , Dictyostelium/growth & development , Nuclear Proteins/biosynthesis , Transcription Factors/metabolism , Active Transport, Cell Nucleus , Adenylyl Cyclases/genetics , Animals , Cell Communication , Gene Expression Regulation , Morphogenesis , Protozoan Proteins/metabolism , STAT Transcription Factors
11.
Am J Obstet Gynecol ; 184(5): 991-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11303210

ABSTRACT

OBJECTIVE: The aim of this study was to assess the use of circulating trophoblast cells in maternal peripheral blood for noninvasive prenatal diagnosis of numeric chromosomal aberrations. STUDY DESIGN: A combined procedure for immunocytochemical identification and deoxyribonucleic acid fluorescence in situ hybridization was used after a single enrichment step consisting of density gradient centrifugation. A specific HLA-G monoclonal antibody was used in combination with X and Y chromosome specific probes in deoxyribonucleic acid fluorescence in situ hybridization to confirm fetal identity of cells bearing HLA-G in the case of a male fetus. RESULTS: We detected fetal trophoblast cells expressing HLA-G in maternal blood starting at 9 weeks' gestation. In addition to fetal sex prediction with X and Y chromosome-specific probes, fetal aneuploidy was confirmed in peripheral blood from a pregnancy complicated by trisomy 21. CONCLUSION: Although the numbers of fetal cells were extremely low, the proof of concept was demonstrated. Early noninvasive prenatal screening for numeric chromosomal abnormalities with fetal trophoblast cells is feasible.


Subject(s)
HLA Antigens/biosynthesis , Histocompatibility Antigens Class I/biosynthesis , Pregnancy Trimester, First/immunology , Trophoblasts/immunology , Antibodies, Monoclonal , Centrifugation, Density Gradient , Chromosome Aberrations , Female , HLA Antigens/blood , HLA-G Antigens , Histocompatibility Antigens Class I/blood , Humans , Immunohistochemistry , Immunophenotyping , In Situ Hybridization, Fluorescence , Pregnancy , Prenatal Diagnosis/methods , Sex Determination Analysis , Trophoblasts/cytology , Trophoblasts/metabolism
12.
Prenat Diagn ; 21(13): 1142-5, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11787040

ABSTRACT

In a woman with a partial hydatidiform molar pregnancy with 69,XXY karyotype, the presence of male fetal cells of trophoblastic origin was demonstrated in maternal blood by X/Y-chromosome specific PCR and by immunostaining combined with FISH on two cell populations isolated from maternal blood. Blood was obtained three weeks prior to the detection of fetal demise, at 13 weeks' gestation. Results were confirmed on formalin-fixed paraffin-embedded molar tissue, removed at 16 weeks' gestational age for therapeutic reasons. The results indicate that both plasma and cells from maternal peripheral blood might be useful for non-invasive prenatal diagnosis of fetal aneuploidies, as described in the current case with a partial molar pregnancy.


Subject(s)
Hydatidiform Mole/genetics , Trisomy , Trophoblasts/ultrastructure , Uterine Neoplasms/genetics , Dilatation and Curettage , Female , Gestational Age , Humans , Hydatidiform Mole/surgery , Immunohistochemistry , In Situ Hybridization, Fluorescence , Male , Polymerase Chain Reaction , Pregnancy , Tissue Embedding , Uterine Neoplasms/surgery , X Chromosome , Y Chromosome
14.
Exp Cell Res ; 245(1): 179-85, 1998 Nov 25.
Article in English | MEDLINE | ID: mdl-9828114

ABSTRACT

During Dictyostelium development, the differentiation inducing factor (DIF) triggers expression of the prestalk gene ecmB and induces stalk cell differentiation, a form of programmed cell death. The effects of DIF are mediated by a sustained increase in cytosolic Ca2+ levels. The Ca2+ ATPase inhibitor BHQ causes a similar rise in Ca2+ levels and also induces prestalk gene expression. We show here that Ca2+ is a specific intermediate for prestalk gene induction, since BHQ represses transcription of the cAMP-inducible aggregative gene PDE, the postaggregative gene CP2, and the prespore gene D19. The prestalk gene ecmA is also induced by DIF, but induction appears to occur in two steps, which occur within 1 h and after 2 h, respectively. The slow step shows the same kinetics as ecmB induction and similar to ecmB induction, this step is BHQ inducible and requires an initial round of protein synthesis. The fast step does not require protein synthesis and cannot be induced by BHQ. This indicates that in addition to the slow Ca2+-mediated pathway, there is probably a second fast Ca2+-independent signal transduction pathway for DIF.


Subject(s)
Dictyostelium/genetics , Extracellular Matrix Proteins/genetics , Hexanones/metabolism , Protozoan Proteins/genetics , Signal Transduction , Animals , Calcium/metabolism , Gene Expression Regulation , Genes, Protozoan , Transcriptional Activation
15.
Mol Cell Biol ; 18(10): 5744-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9742091

ABSTRACT

Serpentine receptors such as smoothened and frizzled play important roles in cell fate determination during animal development. In Dictyostelium discoideum, four serpentine cyclic AMP (cAMP) receptors (cARs) regulate expression of multiple classes of developmental genes. To understand their function, it is essential to know whether each cAR is coupled to a specific gene regulatory pathway or whether specificity results from the different developmental regulation of individual cARs. To distinguish between these possibilities, we measured gene induction in car1 car3 double mutant cell lines that express equal levels of either cAR1, cAR2, or cAR3 under a constitutive promoter. We found that all cARs efficiently mediate both aggregative gene induction by cAMP pulses and induction of postaggregative and prespore genes by persistent cAMP stimulation. Two exceptions to this functional promiscuity were observed. (i) Only cAR1 can mediate adenosine inhibition of cAMP-induced prespore gene expression, a phenomenon that was found earlier in wild-type cells. cAR1's mediation of adenosine inhibition suggests that cAR1 normally mediates prespore gene induction. (ii) Only cAR2 allows entry into the prestalk pathway. Prestalk gene expression is induced by differentiation-inducing factor (DIF) but only after cells have been prestimulated with cAMP. We found that DIF-induced prestalk gene expression is 10 times higher in constitutive cAR2 expressors than in constitutive cAR1 or cAR3 expressors (which still have endogenous cAR2), suggesting that cAR2 mediates induction of DIF competence. Since in wild-type slugs cAR2 is expressed only in anterior cells, this could explain the so far puzzling observations that prestalk cells differentiate at the anterior region but that DIF levels are actually higher at the posterior region. After the initial induction of DIF competence, cAMP becomes a repressor of prestalk gene expression. This function can again be mediated by cAR1, cAR2, and cAR3.


Subject(s)
Dictyostelium/metabolism , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , Receptors, Cyclic AMP/metabolism , Adenosine/metabolism , Animals , Cell Line , Cyclic AMP/metabolism , Cyclic AMP/pharmacology , Dictyostelium/drug effects , Dictyostelium/genetics , Extracellular Matrix Proteins/genetics , Fungal Proteins/genetics , Lymphokines/metabolism , Protozoan Proteins/genetics , Receptors, Cyclic AMP/genetics , Transcriptional Activation
16.
Leukemia ; 11(10): 1762-8, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9324298

ABSTRACT

In this study, we evaluated the effect of hyperthermia on hematopoietic progenitors from six chronic myeloid leukemia (CML) bone marrow (BM) samples at diagnosis and four peripheral blood stem cell (PBSC) samples from CML patients after stem cell mobilisation. CD34-positive cells, isolated from these samples, were incubated for 2 h at 37, 42 or 43 degrees C and were plated in the colony-forming unit granulocyte-macrophage (CFU-GM) and the long-term culture initiating cell (LTCIC) assay. To evaluate purging, individual colonies from these assays were analyzed for the presence of the bcr-abl gene with interphase fluorescence in situ hybridization (FISH) and/or RT-PCR. BM samples showed a significant higher sensitivity both at the CFU-GM and LTCIC level, after treatment at 42 degrees C, as compared to the control BM samples obtained from healthy volunteers. The four BM samples of CML patients with a low leukocyte number at diagnosis harbored a mixture of bcr-abl-negative and positive colonies and an increase in the percentage of bcr-abl-negative colonies was observed in all cases. CML patients with a high leukocyte count at diagnosis, however, showed only bcr-abl-positive progenitors even after hyperthermia. PBSCs showed a significant higher sensitivity at the LTCIC level but not at the CFU-GM level, after treatment at 42 degrees C, as compared to the control PBSC samples obtained from nonhematologic cancer patients. Molecular analysis of individual colonies demonstrated an increase of bcr-abl-negative progenitors after thermic treatment in two out of three samples. When comparing both stem cell sources, PBSCs showed a decreased thermic sensitivity as compared to the BM samples at the CFU-GM level, whereas at the LTCIC level an increased thermic sensitivity was observed, both for the controls and the CML samples. In conclusion, both for BM and PBSCs samples, CML progenitors are more sensitive to hyperthermia than control cells, especially at the LTCIC level. In agreement with these results, an increase of bcr-abl-negative progenitors in six out of seven samples could be demonstrated either at the CFU-GM level, LTCIC level or both. Hyperthermia should be explored further as a possible purging modality in CML.


Subject(s)
Fusion Proteins, bcr-abl/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Hyperthermia, Induced , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Adult , Antigens, CD34/metabolism , Female , Humans , Male , Middle Aged , Sensitivity and Specificity
17.
Hum Mol Genet ; 6(6): 859-67, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9175731

ABSTRACT

Here we describe the cloning of the human Achaete Scute Homologue 2 (HASH2) gene, officially designated ASCL2 (Achaete Scute complex like 2), a homologue of the Drosophila Achaete and Scute genes. In mouse, this gene is imprinted and maps to chromosome 7. We mapped the human homologue close to IGF2 and H19 at 11p15.5, the human region syntenic with mouse chromosome 7, indicating that this imprinted region is highly conserved in mouse and man. HASH2 is expressed in the extravillus trophoblasts of the developing placenta only. The lack of HASH2 expression in non-malignant hydatidiform (androgenetic) moles indicates that HASH2 is also imprinted in man.


Subject(s)
Chromosomes, Human, Pair 11 , DNA-Binding Proteins/genetics , Transcription Factors , Amino Acid Sequence , Animals , Base Sequence , Basic Helix-Loop-Helix Transcription Factors , Chromosome Mapping , Cloning, Molecular , DNA, Complementary , Gene Expression , Humans , Insulin-Like Growth Factor II/genetics , Mice , Molecular Sequence Data , Rats , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid , Trophoblasts/metabolism
19.
Ned Tijdschr Geneeskd ; 140(46): 2296-8, 1996 Nov 16.
Article in Dutch | MEDLINE | ID: mdl-8984385

ABSTRACT

In order to determine the prevalence of HIV in the general heterosexual population of Amsterdam, 16,709 pregnant women attending two hospitals and one maternity clinic in the period 1988-1995 were asked to undergo a HIV test, of whom 15,276 gave informed consent (91.4%). Pregnant women with a risk of HIV infection were possibly overrepresented in those who refused. The overall HIV prevalence in 1988-1995 was 0.28% and showed no significant differences over the years. In women with a known risk factor for infection the prevalence was 240:10,000, in those without 5:10,000. Whereas intravenous drug use was the most probable cause of infection before 1993, since then it was observed in only 2/20 of the HIV positive pregnant women. Heterosexual transmission appears to be increasing.


Subject(s)
AIDS Serodiagnosis , HIV Seroprevalence , Pregnancy Complications, Infectious/virology , Adult , Female , Humans , Netherlands/epidemiology , Pregnancy , Risk Factors , Sexual Behavior , Substance Abuse, Intravenous/complications
20.
Am J Obstet Gynecol ; 174(3): 871-8, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8633658

ABSTRACT

OBJECTIVE: Fetal cells circulate in the maternal blood during early pregnancy. Because these cells are rare, noninvasive prenatal diagnosis from fetal cells can be achieved only after efficient enrichment procedures. Our aim was to develop a two-step enrichment procedure to isolate trophoblast cells from 20 ml of peripheral blood. STUDY DESIGN: Blood was obtained from pregnant women between 6 and 15 weeks of gestation, before invasive procedures were performed. After enrichment, the success of isolating fetal cells was determined by amplification of Y chromosome sequences. RESULTS: A highly specific X/Y polymerase chain reaction was established, sensitive enough to detect X and Y chromosome-specific sequences in one single cell and in one male among 100,000 female cells. Sex determination by polymerase chain reaction was compared with results from conventional karyotyping. The success rate was 91.7%. CONCLUSION: Enrichment of trophoblast cells from maternal blood as described here might be useful for early noninvasive prenatal diagnosis.


Subject(s)
DNA/blood , Fetus/cytology , Pregnancy/blood , Trophoblasts/cytology , X Chromosome/genetics , Y Chromosome/genetics , Base Sequence , Cell Separation/methods , Female , Fetus/metabolism , Humans , Male , Molecular Sequence Data , Polymerase Chain Reaction/methods , Pregnancy Trimester, First , Prenatal Diagnosis/methods , Sex Determination Analysis/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...